Over 64,000 pounds of butter recalled over allergen concerns
The voluntary recall was initiated July 14 by food ingredient company Bunge North America, affecting 1,800 cases of its NH European Style Butter Blend which did not declare milk as an allergen on the label.
As of July 30, the Food and Drug Administration (FDA) labeled it a Class II recall, the second-highest risk level. A Class II recall is 'a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote,' according to the FDA.
The butter was sent to 12 distribution centers located throughout the U.S., as well as a single distribution center located in the Dominican Republic.
Affected cases were packaged in white paperboard and contained 36 blocks.
Affected cases of butter contain the following identification information:
Product code: 5023937
UPC: 1 00 78684 73961 2
Lot code: 5064036503
The butter recall is the latest in a string of food-and-drink-related issues across the U.S.
Earlier this week, High Noon Hard Seltzers were recalled over a labeling error. Some cans, filled with High Noon Vodka Seltzer, were mislabeled as the non-alcoholic Celsius Astro Vibe Energy Drink, Sparkling Blue Razz Edition. As a result, drinking the beverage in these cans can result in unintentional alcohol consumption.
However, no illnesses or adverse events have been reported to date.
Two lots of the High Noon Beach Variety 12-packs were affected, according to a press release. High Noon initiated the recall after it discovered 'a shared packaging supplier mistakenly shipped empty Celsius cans to High Noon,' according to the press release.
The recalled High Noon Beach Variety 12-packs were sent to distributors in eight states who then shipped the product to retailers in six states — Florida, New York, Ohio, South Carolina, Virginia, and Wisconsin — between July 21 and 23.
Even if they didn't purchase the High Noon packs, consumers are encouraged to ensure that their Celsius Astro Vibe Energy Drink, Sparkling Blue Razz Edition, does not have the same lot codes as the recalled cans.
Single-serve coffee pods have also been recalled this week.
New Mexico Piñon Coffee announced in a press release that it was voluntarily recalling 154 boxes of its Dark Pinon Single Serve Cups, which have 10 pods per box. The recall was issued because of the 'potential introduction of food coloring into the cups,' which are compatible with Keurig machines, during brewing.
The recalled coffee pods were sold at popular retailers nationwide, including Target, Costco, Walmart, and Kroger.
Although there weren't any reports of illness or injury, consumers are urged to throw affected pods away or return them to the place of purchase.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Boston Globe
27 minutes ago
- Boston Globe
The FDA is targeting orange juice. Here's why, and what the science says.
Orange juice contains nutrients including calcium and Vitamin C. But some nutritionists argue that's not enough to make up for the unnecessary calories and natural sugars. 'Juices are a dilemma,' said Peter Lurie, the executive director of the nonprofit Center for Science in the Public Interest, which advocates for a healthy and safe food supply. Get Winter Soup Club A six-week series featuring soup recipes and cozy vibes, plus side dishes and toppings, to get us all through the winter. Enter Email Sign Up The American Academy of Pediatrics recommends instead eating real fruit, which contains more fiber than juice. The association advises against giving fruit juice to infants except to manage constipation. It also advises limiting how much juice parents should give older children, such as no more than 4 ounces per day for kids 1 to 3 years old. Advertisement 'If you're going to have a small amount of juice, it's not going to be anything that anybody's going to worry about,' said Marion Nestle, a retired professor of nutrition, food studies and public health at New York University who called fruit juices 'delicious.' 'When you worry about juice is when it's in large amounts,' she added. Advertisement Even though leading orange juice brands do not contain added sugars, high levels of natural sugars can still be harmful, some experts said. 'Orange juice is sugar water,' said Barry Popkin, a professor of nutrition at the University of North Carolina. 'Every juice is essentially sugar water.' Once touted as part of a balanced breakfast, Americans are souring on orange juice. Consumers have gravitated toward other beverage options seen as healthier. Prices have risen. Production has stalled. And this has become a problem for Florida's orange producers. The sugar content of the fruit grown in the state has been steadily dropping due to a bacterial disease afflicting the crop, exacerbated after Hurricane Irma struck in 2017. In 2022, Florida trade groups representing the state's citrus growers and citrus juice industry petitioned the FDA to lower the minimum fruit sugar levels for pasteurized orange juice. The FDA sets a minimum standard for the sugar content in order to call a drink 'pasteurized orange juice,' the kind commonly sold at grocery stores without added sugars. If manufacturers fall below that threshold, they are essentially no longer allowed to call their products 'pasteurized orange juice." Florida orange industry groups said lowering that threshold would protect their business and reduce orange imports from other countries while going unnoticed by consumers. Sugar per serving would lower from 18 grams to 17 grams, according to nutritional label samples provided to the FDA by the industry. Other nutrients would be largely unaffected to the change. Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary both pledged to examine this proposal during congressional hearings when pressed by Sen. Ashley Moody (R-Florida). Advertisement Some nutrition experts said if Kennedy wanted to advance his 'Make America Healthy Again' agenda, which included pledges to improve the diets of children, he should champion more sweeping regulations broadly targeting sugars and sodium. 'If one is serious about sugar in the American diet, we need an across the board approach,' Lurie said.


Business Wire
27 minutes ago
- Business Wire
Bone Solutions Announces Five New Patents Awarded in FY25, Further Enhancing Its Core Mg OSTEOCRETE Technology
COLLEYVILLE, Texas--(BUSINESS WIRE)-- Bone Solutions Inc., an orthobiologics technology company located in Colleyville, Texas, announced today its fifth patent awarded this year from the U.S. Patent and Trademark Office (USPTO) related to Mg OSTEOCRETE, a portfolio of patents that includes current and future configurations, as well as novel delivery systems. "Bone Solutions is furthering its mission to improve patient outcomes." These five patents further expand Bone Solutions' industry footprint and allow surgeons and patients to further benefit from the advantages of the Bone Solutions proprietary magnesium-based technology. Mg OSTEOCRETE and Mg OSTEOINJECT (an injectable version of the product) are fast-setting bone substitutes that remodel into bone over time through creeping substitution, meaning they provide needed support to the defect or void during the healing process while transforming into bone at an optimal rate. 'We are pleased to announce the addition of five new patents supplementing our various technologies, ensuring our continued growth and profitability for the company's future,' said Drew Diaz, CEO of Bone Solutions. 'By leveraging our existing technology, Bone Solutions is furthering its mission to improve patient outcomes through our superior magnesium-based orthopedic solutions." The magnesium component of Mg OSTEOCRETE is the significant differentiator from other bone substitutes on the market. The crystallization reaction from magnesium oxide and the blend of phosphate-based materials allows for ideal osteoconductivity of the product. As a result, Mg OSTEOCRETE and Mg OSTEOINJECT set and cure in situ without migration. The material stimulates cell adhesion, proliferation, and formation of the bone extracellular matrix by osteoblast cells, thus promoting bone growth. In addition to the superior biological performance of the material, the handling characteristics and formulation are ideal for clinical use. Ready for use after only 30 seconds of mixing, the material is moldable or injectable and is cohesive and adhesive to the area it fills. Once implanted, the material sets quickly, is drillable after only two minutes, and is also radiopaque. Mg OSTEOCRETE and Mg OSTEOINJECT are currently being distributed to facilities and surgical centers nationwide for immediate clinical use. About Bone Solutions Inc. Bone Solutions Inc. is a specialized medical device company dedicated to improving clinical outcomes through biologically safe, fully resorbable magnesium-based orthopedic implant solutions, with a focus on addressing complex procedures and cost reduction. The company is developing various new orthopedic technologies within its FDA-cleared magnesium-based platform.


TechCrunch
27 minutes ago
- TechCrunch
Linda Yaccarino joins health tech platform eMed as CEO after leaving X
Linda Yaccarino's next role after departing X as CEO will be another chief executive role at eMed Population Health, an AI startup building a tech platform for patients using GLP-1s. Yaccarino was a longtime advertising executive at NBCUniversal, but left to join X as CEO for two years, where she managed to have a positive impact on the social network's troubled ad revenue model, despite her and Elon Musk's shared approach to minimizing content moderation. Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her 'undeniable ability to negotiate new partnerships' — it certainly also helps that her tenure at X made her well-known in the tech world, drawing more eyes toward the startup. eMed previously produced a tech platform that was designed to be used with at-home COVID-19 rapid antigen tests, guiding users through the process of administering these tests properly. Now, eMed is focused on GLP-1s, the class of drugs like Ozempic, which can be used for both weight management and treatment of type II diabetes. 'To be a leader in today's healthcare marketplace, companies need to have a fearless tenacity that allows them to not only grow, but to also be brave enough to step forward and redefine an entire industry,' Yaccarino said in a press release. 'We are very well-positioned to be that tenacious leader, striving toward our ultimate goal of improving global healthcare outcomes through our groundbreaking services and platforms.'